47 related articles for article (PubMed ID: 35280771)
41. Current and future therapeutic approaches for osteosarcoma.
Harrison DJ; Geller DS; Gill JD; Lewis VO; Gorlick R
Expert Rev Anticancer Ther; 2018 Jan; 18(1):39-50. PubMed ID: 29210294
[TBL] [Abstract][Full Text] [Related]
42. Small non-coding RNA and cancer.
Romano G; Veneziano D; Acunzo M; Croce CM
Carcinogenesis; 2017 May; 38(5):485-491. PubMed ID: 28449079
[TBL] [Abstract][Full Text] [Related]
43. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
Mathew B; Lennon FE; Siegler J; Mirzapoiazova T; Mambetsariev N; Sammani S; Gerhold LM; LaRiviere PJ; Chen CT; Garcia JG; Salgia R; Moss J; Singleton PA
Anesth Analg; 2011 Mar; 112(3):558-67. PubMed ID: 21156980
[TBL] [Abstract][Full Text] [Related]
44. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia.
Farooqui M; Li Y; Rogers T; Poonawala T; Griffin RJ; Song CW; Gupta K
Br J Cancer; 2007 Dec; 97(11):1523-31. PubMed ID: 17971769
[TBL] [Abstract][Full Text] [Related]
45. Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis.
Cheng WF; Chen LK; Chen CA; Chang MC; Hsiao PN; Su YN; Lee CN; Jeng HJ; Hsieh CY; Sun WZ
Mol Ther; 2006 Jan; 13(1):203-10. PubMed ID: 16140583
[TBL] [Abstract][Full Text] [Related]
46. Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors.
Commiskey S; Fan LW; Ho IK; Rockhold RW
J Pharmacol Sci; 2005 Jun; 98(2):109-16. PubMed ID: 15942128
[TBL] [Abstract][Full Text] [Related]
47. Butorphanol Suppresses the Proliferation and Migration of Osteosarcoma by Promoting the Expression of piRNA hsa_piR_006613.
Cui P; Xin D; Li F; Deng L; Gao Y
Front Oncol; 2022; 12():775132. PubMed ID: 35280771
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
